PCI Biotech Holding ASA (PCIB) — Strategic Asset Allocation Index
PCI Biotech Holding ASA (PCIB) has a Strategic Asset Allocation Index of 6.8% as of June 2025. Strategic assets (PP&E of Nkr855.00K plus long-term investments of Nkr-) total Nkr855.00K, measured against net assets of Nkr12.52 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
PCI Biotech Holding ASA Strategic Asset Allocation Index (2008–2024)
This chart shows how PCI Biotech Holding ASA's Strategic Asset Allocation Index has evolved across 16 annual periods from 2008 to 2024. As of June 2025, the index stands at 6.8%, representing strategic assets of Nkr855.00K against net assets of Nkr12.52 Million NOK. Explore cash efficiency ratio of PCI Biotech Holding ASA to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for PCI Biotech Holding ASA (2008–2024)
The table below presents the year-by-year Strategic Asset Allocation Index for PCI Biotech Holding ASA from 2008 to 2024, covering 16 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see PCIB stock market capitalisation.
| Year | SAAI | Strategic Assets (NOK) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 1.3% | Nkr310.00K | Nkr310.00K | Nkr- | Nkr23.45 Million | ▲ +0.6 pp |
| 2023 | 0.8% | Nkr297.00K | Nkr297.00K | Nkr- | Nkr39.04 Million | ▼ -0.5 pp |
| 2022 | 1.3% | Nkr723.00K | Nkr723.00K | Nkr- | Nkr57.40 Million | ▼ -5.5 pp |
| 2021 | 6.7% | Nkr7.66 Million | Nkr7.66 Million | Nkr- | Nkr113.79 Million | ▲ +2.5 pp |
| 2020 | 4.2% | Nkr7.99 Million | Nkr7.99 Million | Nkr- | Nkr189.24 Million | ▲ +1.8 pp |
| 2019 | 2.5% | Nkr6.28 Million | Nkr6.28 Million | Nkr- | Nkr254.83 Million | ▲ +2.5 pp |
| 2018 | 0.0% | Nkr17.00K | Nkr17.00K | Nkr- | Nkr339.95 Million | ▼ 0.0 pp |
| 2017 | 0.1% | Nkr22.00K | Nkr22.00K | Nkr- | Nkr41.84 Million | ▲ +0.0 pp |
| 2016 | 0.0% | Nkr5.00K | Nkr5.00K | Nkr- | Nkr13.09 Million | ▲ +0.0 pp |
| 2015 | 0.0% | Nkr10.00K | Nkr10.00K | Nkr- | Nkr44.28 Million | ▼ -0.1 pp |
| 2014 | 0.2% | Nkr14.00K | Nkr14.00K | Nkr- | Nkr9.11 Million | ▲ +0.1 pp |
| 2013 | 0.0% | Nkr18.00K | Nkr18.00K | Nkr- | Nkr43.40 Million | ▲ +0.0 pp |
| 2011 | 0.0% | Nkr17.00K | Nkr17.00K | Nkr- | Nkr92.53 Million | ▼ -0.1 pp |
| 2010 | 0.1% | Nkr78.00K | Nkr78.00K | Nkr- | Nkr105.42 Million | ▼ -0.4 pp |
| 2009 | 0.4% | Nkr153.00K | Nkr153.00K | Nkr- | Nkr35.08 Million | ▲ +0.2 pp |
| 2008 | 0.2% | Nkr119.00K | Nkr119.00K | Nkr- | Nkr49.30 Million | — |